Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 06, 2020 16:49 ET | Source: Novavax, Inc.

Novavax and Serum Institute of India Announce Development and Commercial Collaboration

Expected to support minimum of 1 billion doses of NVX-CoV2373 for India and low- and middle-income countriesLeverages Serum Institute’s existing reach and infrastructure Builds on and complements...
August 06, 2020 06:45 ET | Source: Novavax, Inc.

Novavax to Host Conference Call to Discuss Second Quarter Financial and Operating Results on August 10, 2020

GAITHERSBURG, Md., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
August 04, 2020 16:05 ET | Source: Novavax, Inc.

Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate

Phase 1 portion of the Phase 1/2 clinical trial evaluated two doses of Novavax’ COVID-19 vaccine across two dose levels (5 and 25 µg) in 131 healthy adults ages 18-59 yearsNVX-CoV2373 was generally...
July 23, 2020 16:02 ET | Source: Novavax, Inc.

Novavax and FUJIFILM Diosynth Biotechnologies Initiate Large Scale Manufacturing of COVID-19 Vaccine Candidate

GAITHERSBURG, Md. and MORRISVILLE, N.C., July 23, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious...
July 20, 2020 16:05 ET | Source: Novavax, Inc.

Novavax to Present COVID-19 Vaccine Candidate Progress at 2nd ISV COVID-19 Vaccines Virtual Congress

GAITHERSBURG, Md., July 20, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
July 07, 2020 06:00 ET | Source: Novavax, Inc.

Novavax Announces $1.6 Billion Funding from Operation Warp Speed

Funding supports late-stage clinical development, including pivotal Phase 3 clinical trial to support licensure OWS award funds large-scale manufacturing of NVX-CoV2373, including production of 100...
July 02, 2020 08:30 ET | Source: Novavax, Inc.

Novavax Announces Updates to Leadership Team

Frank Czworka appointed SVP, Global Sales Brian Webb promoted to SVP, Manufacturing GAITHERSBURG, Md., July 02, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology...
June 29, 2020 08:42 ET | Source: Novavax, Inc.

Novavax Expands Executive Leadership and Announces Key Promotions

GAITHERSBURG, Md., June 29, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
June 24, 2020 08:00 ET | Source: Novavax, Inc.

Novavax to Participate in H.C. Wainwright Fireside Chat Series

GAITHERSBURG, Md., June 24, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
June 17, 2020 08:00 ET | Source: Novavax, Inc.

Novavax Announces Additions to Executive Leadership

GAITHERSBURG, Md., June 17, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right